Advertisement
Abstract

Quantification of the in vivo potency of the adenosine A2 receptor antagonist 8-(3-chlorostyryl)caffeine.

R A Mathôt, J M Gubbens-Stibbe, W Soudijn, K A Jacobson, A P Ijzerman and M Danhof
Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 245-253;

Article Information

vol. 275 no. 1 245-253
PubMed 
7562557
Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0022-3565
Online ISSN 
1521-0103
History 
  • Published online October 1, 1995.

Author Information

  1. R A Mathôt,
  2. J M Gubbens-Stibbe,
  3. W Soudijn,
  4. K A Jacobson,
  5. A P Ijzerman and
  6. M Danhof
  1. Division of Pharmacology, Leiden/Amsterdam Center for Drug Research, University of Leiden, The Netherlands.

Statistics from Altmetric.com

Article usage

Article usage: July 1999 to August 2022

AbstractFullPdf
Jul 1999100
Jan 2001100
Mar 2001300
May 2001200
Jun 2001100
Feb 2002200
Mar 2002100
Nov 2002100
Dec 2002100
Jan 2003100
Feb 2003100
Jul 2003400
Aug 2003100
Sep 2003500
Oct 2003500
Nov 2003500
Dec 2003200
Jan 2004500
Feb 2004500
Mar 2004200
Apr 2004500
May 2004500
Jun 2004800
Jul 20041100
Aug 2004500
Sep 2004500
Oct 2004200
Nov 2004200
Dec 2004100
Jan 2005200
Feb 2005400
Mar 2005700
Apr 2005100
May 2005100
Jun 2005200
Jul 2005200
Aug 2005100
Sep 2005100
Oct 2005500
Nov 2005200
Dec 2005700
Jan 2006100
Feb 2006200
Mar 2006100
Apr 2006102
May 2006100
Jun 2006200
Jul 2006103
Aug 2006100
Sep 2006100
Oct 2006101
Nov 2006100
Dec 2006300
Feb 2007102
Mar 2007100
Apr 2007300
May 2007200
Jun 2007002
Jul 2007201
Aug 2007300
Sep 2007200
Nov 2007201
Dec 2007300
Feb 2008201
Mar 2008202
Apr 2008201
May 2008100
Jun 2008400
Aug 2008202
Sep 2008200
Oct 2008300
Nov 2008501
Dec 2008101
Jan 2009100
Feb 2009101
Mar 2009500
May 2009202
Jun 2009100
Aug 2009304
Sep 2009400
Oct 2009400
Nov 2009500
Dec 2009300
Feb 2010501
Mar 2010002
Apr 2010100
May 2010100
Jun 2010002
Jul 2010004
Aug 2010200
Oct 2010103
Nov 2010100
Dec 2010400
Jan 2011002
Feb 2011403
Mar 2011304
Apr 2011203
May 2011201
Jun 2011301
Jul 2011300
Aug 2011200
Sep 2011100
Oct 2011300
Nov 2011303
Dec 2011300
Jan 2012300
Feb 2012601
Mar 2012101
Apr 2012201
May 2012600
Jun 2012401
Jul 2012400
Aug 2012300
Sep 2012100
Oct 2012200
Nov 2012002
Dec 2012200
Jan 2013101
Feb 2013100
Mar 2013200
Apr 2013200
May 2013200
Jun 2013304
Jul 2013200
Sep 2013800
Oct 2013300
Nov 2013201
Jan 2014100
Feb 2014302
Mar 2014100
Apr 2014300
May 2014001
Jun 2014100
Jul 2014300
Sep 2014100
Oct 2014100
Nov 2014100
Feb 2015100
Mar 2015301
Jun 2015100
Jul 2015200
Sep 2015100
Nov 2015100
Dec 2015300
Jan 2016100
Feb 2016200
Mar 2016501
Jun 2016200
Sep 2016300
Oct 2016401
Nov 20161302
Dec 2016300
Jan 2017100
Feb 2017200
Mar 2017100
Apr 2017302
May 2017300
Jun 2017300
Jul 2017100
Aug 2017100
Sep 2017201
Oct 2017400
Nov 2017100
Dec 2017300
Jan 2018500
Feb 2018701
Mar 2018300
Apr 20181300
May 2018300
Jun 2018400
Aug 2018200
Feb 2019702
Apr 2019201
May 2019100
Jun 2019202
Jul 2019100
Aug 2019100
Sep 2019800
Oct 2019700
Nov 2019700
Dec 2019600
Jan 2020100
Feb 2020500
Mar 2020300
Apr 2020200
Jun 2020100
Jul 2020100
Oct 2020101
Nov 2020600
Dec 2020300
Jan 2021600
Feb 20211000
Mar 2021500
Apr 2021400
May 20212400
Jun 20211300
Jul 2021700
Aug 2021900
Sep 2021600
Oct 2021200
Nov 2021800
Dec 2021100
Jan 2022700
Feb 2022300
Mar 20221400
Apr 20222200
May 2022400
Jun 20221201
Jul 20221400
Aug 2022200

Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

Abstract

Quantification of the in vivo potency of the adenosine A2 receptor antagonist 8-(3-chlorostyryl)caffeine.

R A Mathôt, J M Gubbens-Stibbe, W Soudijn, K A Jacobson, A P Ijzerman and M Danhof
Journal of Pharmacology and Experimental Therapeutics October 1, 1995, 275 (1) 245-253;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo

Jump to section

Related Articles

Cited By...

Similar Articles

Advertisement